132 related articles for article (PubMed ID: 4585343)
1. Tumor immunity induced by BCG-tumor cell mixtures in syngeneic mice.
Tokunaga T; Kataoka T; Nakamura RM; Yamamoto S; Tanaka T
Jpn J Med Sci Biol; 1973 Apr; 26(2):71-85. PubMed ID: 4585343
[No Abstract] [Full Text] [Related]
2. Experimental studies of tumor immunotherapy. II. Tumor immunotherapy following tumor extirpation.
Hayashi S
Acta Med Okayama; 1976 Jun; 30(3):197-208. PubMed ID: 136871
[TBL] [Abstract][Full Text] [Related]
3. Activated macrophages and the antitumor action of BCG.
Alexander P
Natl Cancer Inst Monogr; 1973 Dec; 39():127-33. PubMed ID: 4595313
[No Abstract] [Full Text] [Related]
4. Immunotherapy of guinea pig cancer with BCG.
Zbar B
Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
[No Abstract] [Full Text] [Related]
5. The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer.
Mathé G; Halle-Pannenko O; Bourut C; Hiu IJ
Johns Hopkins Med J Suppl; 1974; 3():85-102. PubMed ID: 4154074
[No Abstract] [Full Text] [Related]
6. Nonspecific resistance to tumor allograft.
Rejthar A; Wotke J; Rejtharová A; Jasková J
Neoplasma; 1975; 22(3):273-8. PubMed ID: 1099469
[TBL] [Abstract][Full Text] [Related]
7. Peritoneal macrophage response to leukemia L1210 in syngeneic mice.
Berd D; Prehn RT
J Natl Cancer Inst; 1977 Jun; 58(6):1729-34. PubMed ID: 864751
[No Abstract] [Full Text] [Related]
8. The balance of host immunocompetence in chemical carcinogenesis and "nonspecific" immunotherapy.
Hanna MG; Szakal AK; Peters LC
Recent Results Cancer Res; 1975; (52):114-36. PubMed ID: 827793
[No Abstract] [Full Text] [Related]
9. Experimental studies of tumor immunotherapy. I. Macrophage migration inhibitory activity as an immunological parameter.
Hayashi S
Acta Med Okayama; 1976 Apr; 30(2):95-106. PubMed ID: 135489
[TBL] [Abstract][Full Text] [Related]
10. Some immunologically based reactions that can cause the regression of large tumor masses.
Alexander P
Natl Cancer Inst Monogr; 1976 Nov; 44():105-8. PubMed ID: 799755
[TBL] [Abstract][Full Text] [Related]
11. Induction of transplantation resistance to murine L1210 leukemia cells in BCG-primed mice by immunization with tuberculin protein-coupled L1210 cells.
Ohno R; Kodera Y; Ogura M; Yamada H
Gan; 1984 Feb; 75(2):187-92. PubMed ID: 6428959
[TBL] [Abstract][Full Text] [Related]
12. The second generation of EORTC-ECIG experimental screening for systemic immunity adjuvants. Its significance for cancer immunotherapy. A comparison of BCG and its hydrosoluble extract.
Mathe G; Halle-Pannenko O; Florentin I; Bruley-Rosset M; Kamel M; Hiu IJ; Bourut C
Eur J Cancer (1965); 1975 Nov; 11(11):801-7. PubMed ID: 767112
[No Abstract] [Full Text] [Related]
13. Antitumor activity of peritoneal exudate cells induced by cell-wall skeleton of Mycobacterium bovis BCG.
Namba M; Ogura T; Hirao F; Azuma I; Yamamura Y
Gan; 1978 Dec; 69(6):831-4. PubMed ID: 374173
[TBL] [Abstract][Full Text] [Related]
14. Immunopotentiation with BCG. 3. Modulation of the response to a tumor-specific antigen.
Hawrylko E; Mackaness GB
J Natl Cancer Inst; 1973 Nov; 51(5):1677-82. PubMed ID: 4587142
[No Abstract] [Full Text] [Related]
15. Macrophages elicited with heat-killed bacillus Calomette-Guérin protect C57BL/6J mice against a syngeneic melanoma.
Freedman VH; Calvelli TA; Silagi S; Silverstein SC
J Exp Med; 1980 Sep; 152(3):657-73. PubMed ID: 6997425
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of cancer: immunospecific rejection of tumors in recipients of neuraminidase-treated tumor cells plus BCG.
Simmons RL; Rios A
Science; 1971 Nov; 174(4009):591-3. PubMed ID: 4940021
[TBL] [Abstract][Full Text] [Related]
17. Studies on the antibody-dependent cell-mediated cytotoxicity (ADCC) of thioglycollate-stimulated and BCG-activated peritoneal macrophages.
Koren HS; Anderson SJ; Adams DO
Cell Immunol; 1981 Jan; 57(1):51-61. PubMed ID: 7011574
[No Abstract] [Full Text] [Related]
18. Tumor immunity produced by the intradermal inoculation of living tumor cells and living Mycobacterium bovis (strain BCG).
Zbar B; Bernstein I; Tanaka T; Rapp HJ
Science; 1970 Dec; 170(3963):1217-8. PubMed ID: 4920656
[TBL] [Abstract][Full Text] [Related]
19. Partial characterization of anti-tumor effector macrophages in the peritoneal cavities of concomitantly immune mice and mice injected with macrophage-stimulating agents.
Hopper KE; Harrison J; Nelson DS
J Reticuloendothel Soc; 1979 Sep; 26(3):259-71. PubMed ID: 115998
[No Abstract] [Full Text] [Related]
20. Immunotherapy of cancer with cell wall skeleton of Myocabacterium bovis-Bacillus Calmette-Guérin: experimental and clinical results.
Yamamura Y; Azuma I; Taniyama T; Sugimura K; Hirao F; Tokuzen R; Okabe M; Nakahara W; Yasumoto K; Ohta M
Ann N Y Acad Sci; 1976; 277(00):209-27. PubMed ID: 826205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
